-
Early Keytruda Results Win Merck An Upgrade
Tuesday, January 16, 2018 - 2:19pm | 345Read More...Merck & Co., Inc. (NYSE: MRK) announced encouraging data Tuesday from a key study of patients with lung cancer. The combination of Merck's blockbuster drug Keytruda and two chemotherapy medicines helped patients live longer and played a role in stopping the disease from advancing...
-
A Peek Into The Markets: U.S. Stock Futures Gain; Yellen Testimony In Focus
Wednesday, July 12, 2017 - 7:35am | 441Read More...Pre-open movers U.S. stock futures traded higher in early pre-market trade. Federal Reserve Chair Janet Yellen is set to testify before the House Financial Services Committee at 10:00 a.m. ET. The Federal Open Market Committee will release Beige book report at 2:00 p.m. ET. Kansas City Federal...
-
WideOpenWest Quiet Period Expires
Monday, June 19, 2017 - 12:03pm | 441Read More...WideOpenWest Inc (NYSE: WOW) shares are down 1.6 percent on Monday after a tidal wave of Wall Street analysts commented on the stock on Monday. WideOpenWest’s May 25 IPO has mostly been a disappointment for investors. The stock debuted roughly $1 below its $17 price, an in its first 25 days...
-
Analyst On La Jolla's Hypotension Drug: We Expect Approval Next Year
Monday, May 22, 2017 - 11:23am | 611Read More...Following the publication of full data from a late-stage study of La Jolla Pharmaceutical Company (NASDAQ: LJPC)'s LPJC-501, a proprietary formulation of angiotensin II, SunTrust Robinson Humphrey said it expects approval in 2018. The Study And The Results The full data from the Phase III study,...
-
Sarepta Gets An Upgrade; Cardiac, Pulmonary Function Could Provide Added Clinical Support For Exondys
Wednesday, April 5, 2017 - 9:05am | 313Read More...Sarepta Therapeutics Inc (NASDAQ: SRPT) presented encouraging long-term cardiac and pulmonary data at the MDA Scientific Conference. The data could provide “additional support for the clinical benefit from Exondys 51 treatment,” SunTrust Robinson Humphrey’s Edward Nash said in a...
-
Bob Peck: Holiday Shopping Forecast Suggests Amazon, eBay Will Meet Estimates
Monday, November 21, 2016 - 12:02pm | 352Read More...According to comScore, digital e-commerce spending will grow in the 2016 holiday season by 16–19 percent to $79 billion–$81 billion, representing an acceleration in growth compared to a year ago. Robert "Bob" S. Peck of SunTrust Robinson Humphrey pointed out that over the past two years...
-
3 Worries For Facebook: Fake News, Ads And Analytics
Thursday, November 17, 2016 - 9:58am | 302Read More...While mentioning three investor concerns around Facebook Inc (NASDAQ: FB), SunTrust Robinson Humphrey’s Bob Peck noted in a report that none of these were currently significant enough to impact the company’s financials. He maintained a Buy rating on Facebook, with a price target of...
-
SunTrust Admits They Were Wrong On Fitbit, Downgrades Stock To Hold
Thursday, November 3, 2016 - 9:57am | 297Read More...Although Fitbit Inc (NYSE: FIT) reported broadly in-line Q3 results, its Q4 guidance implied a sharp decline, raising questions around “customer demand, and the category's maturity,” SunTrust Robinson Humphrey’s Robert S. Peck said in a report. He downgraded the rating on the...
-
Alphabet Showed 'Clinical Execution' On Tough Comps
Friday, October 28, 2016 - 10:49am | 316Read More...Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) reported strong quarterly results, as the company achieved growth and margin expansion. Google “continues to balance LT growth investments (i.e. Cloud), with capital returns (announcing a $7 billion buyback),” SunTrust Robinson Humphrey’...
-
Twitter's Overall Trends Remain Challenged, Q4 Will Be Very Critical
Friday, October 28, 2016 - 10:38am | 274Read More...Twitter Inc (NYSE: TWTR) reported better Q3 results against low expectations. The company guided to revenue deceleration and margin compression in Q4, amid its ongoing platform turnaround. “Given the ongoing challenges we do not think a premium multiple is warranted,” SunTrust...
-
6 Key Takeaways From Amazon's Q3 Earnings
Friday, October 28, 2016 - 10:28am | 325Read More...Amazon.com, Inc. (NASDAQ: AMZN) reported Q3 results with robust unit, revenue and gross profit growth, despite tougher comps. Bob Peck of SunTrust Robinson Humphrey maintained a Hold rating on the company, with a price target of $850. Margin Pressure Peck mentioned that the Q4 margin...
-
10 Questions Yahoo Investors Need Answers To
Wednesday, October 19, 2016 - 9:10am | 510Read More...Although Yahoo! Inc. (NASDAQ: YHOO) reported mixed results, they were overshadowed by the statement made by Verizon Communications Inc. (NYSE: VZ) General Counsel regarding the impact of the hack on the deal. Robert "Bob" S. Peck of SunTrust Robinson Humphrey maintains a Hold rating on the company...
-
SunTrust Warns Of 'Broad Based Slowdown' In Cruise Pricing During September
Wednesday, October 19, 2016 - 8:18am | 449Read More...There is “little to like” in the data revealed by the latest cruise pricing survey, SunTrust Robinson Humphrey’s Patrick Scholes said in a report. He added that there seemed to have been a broad-based slowdown across all global regions. Ad Pricing Down Overall industry-wide...
-
Bob Peck Previews PayPal's Q3 Results: 'Investors Likely To Focus On Impact Of V/MA Deals'
Tuesday, October 11, 2016 - 10:05am | 363Read More...Paypal Holdings Inc (NASDAQ: PYPL) is likely to report its Q3 results in-line with expectations, and investors could focus on the potential impact of the recent agreements with Visa Inc (NYSE: V) and Mastercard Inc (NYSE: MA), SunTrust Robinson Humphrey’s Robert "Bob" S. Peck said in a report...
-
With Slim Chances Of A Buyout, Twitter Needs A Plan C
Tuesday, October 11, 2016 - 8:53am | 390Read More...Twitter Inc (NYSE: TWTR) had been trying to turnaround and its Plan B was the attempted sale of the company. With both these plans seeming unsuccessful, Twitter needs to have a Plan C, SunTrust’s Bob Peck said in a report. He maintained a Hold rating on the company, with a price target of $...















